These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 633484

  • 1. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB, Gunnarsson PO, Nilsson T, Forshell GP.
    Eur J Drug Metab Pharmacokinet; 1981 Feb; 6(2):149-54. PubMed ID: 7274309
    [Abstract] [Full Text] [Related]

  • 3. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
    Sandberg AA.
    Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
    [No Abstract] [Full Text] [Related]

  • 4. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I, Liskowski L, Nilsson T.
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [Abstract] [Full Text] [Related]

  • 6. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
    Kadohama N, Kirdani RY, Madajewicz S, Murphy GP, Sandberg AA.
    N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
    [No Abstract] [Full Text] [Related]

  • 7. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP, Müntzing J, Ek A, Lindstedt E, Dencker H.
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of estramustine phosphate.
    Gunnarsson PO, Forshell GP.
    Urology; 1984 Jun; 23(6 Suppl):22-7. PubMed ID: 6375076
    [No Abstract] [Full Text] [Related]

  • 9. Estramustine phosphate sodium.
    Hauser AR, Merryman R.
    Drug Intell Clin Pharm; 1984 May; 18(5):368-74. PubMed ID: 6373212
    [Abstract] [Full Text] [Related]

  • 10. The hydrolysis of estramustine phosphate; in vitro studies.
    Gunnarsson O, Andersson SB, Johansson SA.
    Eur J Drug Metab Pharmacokinet; 1983 May; 8(4):395-402. PubMed ID: 6673977
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific binding of estramustine to prostatic proteins.
    Forsgren B, Björk P.
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract] [Full Text] [Related]

  • 16. Design of cytotoxic steroids for prostate cancer.
    Petrow V, Padilla GM.
    Prostate; 1986 Jun; 9(2):169-82. PubMed ID: 3748896
    [Abstract] [Full Text] [Related]

  • 17. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD, Rozencweig M, Slavik M, Muggia FM.
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mode of action of Emcyt.
    Høisaeter PA.
    Urology; 1984 Jun; 23(6 Suppl):46-8. PubMed ID: 6375079
    [No Abstract] [Full Text] [Related]

  • 20. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
    Kirdani RY, Karr JP, Murphy GP, Sandberg AA.
    N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.